Munafa Stock Market Course + Intraday & FNO calls 
Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arrowhead Pharmaceuticals (ARWR)
Technical Analysis Report for USA stock ARWR Arrowhead Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARWR Arrowhead Pharmaceuticals then click here. or read Experts views on Arrowhead Pharmaceuticals or Forecast & share price targets of Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Opened at 65.50 and Closed at: 64.52, which is -0.19% of previous session's close. It moved within a range of 63.46 and 68.44
The session was a Bearish session with an average volume of 24090500, which is 86.53% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 8 days back on short term averages
Support for tomorrow is 61.5 and resistance for tomorrow is 66.48
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 62.51, 60.49 resistance for tomorrow's hourly charts is 67.49, 70.45
10 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 68.01 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 67.08 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 65.99 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 51.65 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Arrowhead Pharmaceuticals is 34.69 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arrowhead Pharmaceuticals is at 67.08 and 200 DMA is at 34.69, while 50 DMA and 100 DMA are at 65.99 and 51.65 respectively
Arrowhead Pharmaceuticals (ARWR) moving average of 20 SMA is at 67.08 and 20 EMA is at 67.24
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 64.52 | 67.08 | 67.24 |
| 05 Thu Feb | 64.64 | 67.11 | 67.53 |
| 04 Wed Feb | 68.06 | 67.16 | 67.83 |
| 03 Tue Feb | 72.14 | 67.3 | 67.81 |
| 02 Mon Feb | 73.00 | 66.88 | 67.35 |
| 30 Fri Jan | 69.33 | 66.62 | 66.76 |
Arrowhead Pharmaceuticals (ARWR) moving average of 50 SMA is at 65.99 and 50 EMA is at 62.82
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 64.52 | 65.99 | 62.82 |
| 05 Thu Feb | 64.64 | 65.59 | 62.75 |
| 04 Wed Feb | 68.06 | 65.1 | 62.67 |
| 03 Tue Feb | 72.14 | 64.5 | 62.45 |
| 02 Mon Feb | 73.00 | 63.84 | 62.05 |
| 30 Fri Jan | 69.33 | 63.19 | 61.6 |
Arrowhead Pharmaceuticals (ARWR) moving average of 100 SMA is at 51.65 and 100 EMA is at 53.58
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 64.52 | 51.65 | 53.58 |
| 05 Thu Feb | 64.64 | 51.29 | 53.36 |
| 04 Wed Feb | 68.06 | 50.95 | 53.13 |
| 03 Tue Feb | 72.14 | 50.56 | 52.83 |
| 02 Mon Feb | 73.00 | 50.13 | 52.44 |
| 30 Fri Jan | 69.33 | 49.68 | 52.02 |
Arrowhead Pharmaceuticals (ARWR) moving average of 200 SMA is at 34.69 and 200 EMA is at 42.28
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 64.52 | 34.69 | 42.28 |
| 05 Thu Feb | 64.64 | 34.42 | 42.06 |
| 04 Wed Feb | 68.06 | 34.15 | 41.83 |
| 03 Tue Feb | 72.14 | 33.87 | 41.56 |
| 02 Mon Feb | 73.00 | 33.57 | 41.25 |
| 30 Fri Jan | 69.33 | 33.26 | 40.93 |
Zoetis Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Zoetis Inc, about 0.25% more returns!
Glaxosmithkline Plc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 19.58% more returns!
Arrowhead Pharmaceuticals has performed better than Community Health in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Centene Corporation in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Brookdale Senior has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Brookdale Senior, about 46.28% more returns!
Xtl Biopharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 59.75% more returns!
Arrowhead Pharmaceuticals has performed better than Xbiotech Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Vistagen Therapeutics in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Sellas Life has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Sellas Life, about 7.23% more returns!
Arrowhead Pharmaceuticals has performed better than Sintx Technologies in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Siga Technologies has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Siga Technologies, about 1.41% more returns!
Arrowhead Pharmaceuticals has performed better than Proqr Therapeutics in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Natera Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Intellia Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 18.26% more returns!
Arrowhead Pharmaceuticals has performed better than Kezar Life in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Innoviva Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Innoviva Inc, about 11.39% more returns!
Arrowhead Pharmaceuticals has performed better than Inogen Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Alphatec Holdings in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals Technical analysis of indicators
Price action analysis of Arrowhead Pharmaceuticals (ARWR) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term but the sell signal is initial and weak.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 66.26 and Arrowhead Pharmaceuticals ARWR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals ARWR stock. Volume based technical analysis of Arrowhead Pharmaceuticals ARWR stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARWR Arrowhead Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARWR Experts View which covers a lot of information including buying and selling signals
ARWR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arrowhead Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
